Riskpilot← Back to searchSign inGet full accessMP Läkarkonsult AB
ABIn liquidationOrg 5590255534UppsalaGeneral medical practice activities · NACE 8621Est. 20151 employees
Revenue 2025
SEK 21K
-71% vs 2024
EBITDA margin
-683.1%
+34% vs 2024
Equity ratio
98.3%
Financial strength
Net profit 2025
SEK -131K
+32% vs 2024
| Revenue | SEK 21K | -71% |
| EBITDA | SEK -142K | +34% |
| Net profit | SEK -131K | +32% |
| Total assets | SEK 113K | -67% |
| Equity | SEK 111K | -54% |
| Employees | 1 | — |
Legal name
MP Läkarkonsult AB
Org number
5590255534
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 september 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolagets verksamhet skall vara att bedriva sjukvård som läkare och därmed förenlig verksamhet.
Address
Uppsala
Email
oskar.nordstrom@nordstromadvokater.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 559 | 423 | 425 | 73 | 21 |
| Staff expenses | — | — | −313 | −253 | −142 |
| EBITDA | 88 | 40 | 79 | −214 | −142 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 88 | 40 | 79 | −214 | −142 |
| Net financials | — | — | 1 | 1 | 11 |
| Profit before tax | 88 | 40 | 60 | −193 | −131 |
| Tax | −18 | −8 | −12 | — | — |
| Net profit | 70 | 32 | 48 | −193 | −131 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 483 | 494 | 614 | 338 | 113 |
| Equity | 356 | 387 | 435 | 242 | 111 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 127 | 107 | 159 | 96 | 2 |
| Total debt | 127 | 107 | 159 | 96 | 2 |
EBITDA margin
-683.1%
This company
15.8%
Market median
-4423% vs market
20212025
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
-118.2%
This company
18.4%
Market median
-742% vs market
20212025
Net profit margin
-630.6%
This company
8.1%
Market median
-7885% vs market
20212025
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EO Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MP Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Oskar Nordström | Liquidator | 0 companies |
| Won-Ku Ernst-Erik Krister Karlsson | Deputy Board Member | 0 companies |
| Saga Marianne Pråhl | Board of Directors | 0 companies |